Investment Trust Insider on Blue Prism’s inexorable rise Carthew: the beneficiaries of Blue Prism’s inexorable rise Occasionally, early stage technology companies can produce spectacular share price gains. When this happens, even relatively small investments can make a noticeable difference to a fund’s returns. Regular readers of my column may recall that I wrote about the […]
Investment Trust Insider on ScotGems James Carthew: ScotGems’ soft start needs explanation It has been a busy year for new issues and we still might see a few more make it over the finish line before Christmas. Although property in various forms has been popular, we have also witnessed a few equity trust launches get […]
Investment Trust Insider on the importance of diversification James Carthew: Herald shows Woodford and Biopharma the importance of diversification A month ago I wondered when Biopharma Credit (BPCR), the biggest investment company launch of the year, would get its flotation proceeds invested. Last week it took a big step towards answering this question by committing […]
Investment Trust Insider on Sherborne James Carthew: the trusts that could be Sherborne’s next takeover target At the beginning of July 2017, Sherborne Investors C (SIGC) raised £700 million to ‘realise capital growth from investment in a target company identified by the investment manager with the aim of generating a significant capital return for shareholders.’ […]
QuotedData analyst, Matthew Read, talks to Jennifer Hill at Investment Trust Insider about opportunities within the UK equity income sector. To read the article please click here
James Carthew: new faces and a brighter future for Japan Shinzo Abe, who has just become an internet meme by doing a backward roll into a golf bunker, while hanging out with Donald Trump, has pulled off what Theresa May couldn’t, calling a snap election and securing an increased majority. Japan’s prime minister first secured […]
James Carthew of QuotedData talks to Kate Beioley of Investors Chronicle read more here (subscription required)
The rewards of investment trusts and bargain valuations – a podcast QuotedData’s James Carthew was interviewed for investors’ Chronicle’s latest podcast – listen here
Investment Trust Insider on Princess Private Equity It is 10 years since Princess Private Equity (PEY) listed in London. This private equity fund has had an interesting history, largely by virtue of its willingness to adapt to make itself more appealing. Prior to listing in London, Princess had a listing in Frankfurt but it wanted […]
Investment Trust Insider on BioPharma Credit James Carthew: don’t let Biopharma’s slow start give you the wrong impression (title by Citywire!!) This week I’m revisiting Biopharma Credit (BPCR) which I last wrote about at the end of March, when it listed having raised £610 million. As things stand, it still holds the top slot for […]
